Gnrh
Hyperinsulinemia
University of Colorado, Denverprotein_peptideN/AActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 81/ 100
Competitive context
18 Active assets in the Hyperinsulinemia cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Metformin Attikon Hospital | Phase 4 | BB |
Metformin Attikon Hospital | Phase 4 | BB |
EUDEMINE INJECTION Columbia University | Phase 2 | B |
Insulin-Like Growth Factor I Children's Hospital of Philadelphia | Phase 2 | B |
Rosiglitazone New York Medical College | Phase 2 | B |
View all 25 →
Same molecule, other indications
Gnrh is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →